March 18, 2020 / 2:06 PM / 16 days ago

BRIEF-BGI Genomics Has Filed Pre-Emergency Use Authorization Application To The U.S. FDA For Its New Coronavirus Testing Product

March 18 (Reuters) - BGI Genomics Co Ltd:

* SAYS IT HAS FILED PRE-EMERGENCY USE AUTHORIZATION APPLICATION TO THE U.S. FDA FOR ITS REAL-TIME FLUORESCENT RT-PCR KIT FOR DETECTING SARS-NCOV-2 Source text in Chinese: bit.ly/3a2cnEH Further company coverage: (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below